Literature DB >> 17208079

Trend in mortality after stroke with atrial fibrillation.

Lars Frost1, Ljubica Vukelic Andersen, Peter Vestergaard, Steen Husted, Leif Spange Mortensen.   

Abstract

PURPOSE: To evaluate trend in mortality in stroke associated with atrial fibrillation, we examined mortality trend after stroke with atrial fibrillation by calendar year period (1980-1984, 1985-1989, 1990-1994, 1995-1999, and 2000-2002). We estimated trends separately for each sex in unadjusted analyses. We also adjusted for age, comorbid conditions, and general trend in mortality in the background population.
METHODS: We identified all individuals, aged 40-89 years, with an incident diagnosis of stroke of any nature (ischemic or hemorrhagic) and no history of heart valve disease and a previous or concomitant diagnosis of atrial fibrillation or flutter in the Danish National Registry of Patients. Subjects were followed in the Danish Civil Registration System for emigration and vital status. We used multivariate Cox proportional hazards regression analysis to estimate trend in mortality.
RESULTS: Incident stroke with a previous or concomitant diagnosis of nonvalvular atrial fibrillation or flutter was diagnosed in 24,470 subjects (11,554 men and 12,916 women). During 34,405 years of observation, 9237 men died, and during 35,381 years of observation, 10,827 women died. The hazard ratio for mortality after stroke in the last 3-year period compared with the first 5-year period was .65 (95% confidence interval [CI], .61-.71) in men and .69 (95% CI, .64-.74) in women.
CONCLUSIONS: We observed a substantially better survival in men and women after stroke associated with atrial fibrillation or flutter in Denmark during the years 1980 to 2002. However, we could not control for changes in admission practice, diagnostic performance, or treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17208079     DOI: 10.1016/j.amjmed.2005.12.027

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

1.  The effect of dabigatran and rivaroxaban on platelet reactivity and inflammatory markers.

Authors:  Noa Zemer-Wassercug; Moti Haim; Dorit Leshem-Lev; Katia L Orvin; Muthiah Vaduganathan; Ariel Gutstein; Ehud Kadmon; Aviv Mager; Ran Kornowski; Eli I Lev; Eli L Lev
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

2.  Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

Authors:  Kevin E Chan; J Michael Lazarus; Ravi Thadhani; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

3.  Initiation and persistence with warfarin therapy in atrial fibrillation according to ethnicity.

Authors:  Carolina Malta Hansen; Jonas Bjerring Olesen; Morten Lock Hansen; Aziza Azimi; Christian Torp-Pedersen; Helena Dominguez
Journal:  Front Pharmacol       Date:  2012-06-28       Impact factor: 5.810

4.  Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.

Authors:  Jonas Bjerring Olesen; Gregory Y H Lip; Morten Lock Hansen; Peter Riis Hansen; Janne Schurmann Tolstrup; Jesper Lindhardsen; Christian Selmer; Ole Ahlehoff; Anne-Marie Schjerning Olsen; Gunnar Hilmar Gislason; Christian Torp-Pedersen
Journal:  BMJ       Date:  2011-01-31

5.  Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study.

Authors:  Jesper Lindhardsen; Ole Ahlehoff; Gunnar Hilmar Gislason; Ole Rintek Madsen; Jonas Bjerring Olesen; Jesper Hastrup Svendsen; Christian Torp-Pedersen; Peter Riis Hansen
Journal:  BMJ       Date:  2012-03-08

6.  Ischemic Stroke Severity and Mortality in Patients With and Without Atrial Fibrillation.

Authors:  Naja E Vinding; Søren L Kristensen; Rasmus Rørth; Jawad H Butt; Lauge Østergaard; Jonas B Olesen; Christian Torp-Pedersen; Gunnar H Gislason; Lars Køber; Christina Kruuse; Søren P Johnsen; Emil L Fosbøl
Journal:  J Am Heart Assoc       Date:  2022-02-12       Impact factor: 6.106

7.  The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study.

Authors:  Christian Selmer; Jonas Bjerring Olesen; Morten Lock Hansen; Jesper Lindhardsen; Anne-Marie Schjerning Olsen; Jesper Clausager Madsen; Jens Faber; Peter Riis Hansen; Ole Dyg Pedersen; Christian Torp-Pedersen; Gunnar Hilmar Gislason
Journal:  BMJ       Date:  2012-11-27

8.  Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort study.

Authors:  Ditte-Marie Bretler; Peter Riis Hansen; Jesper Lindhardsen; Ole Ahlehoff; Charlotte Andersson; Thomas Bo Jensen; Jakob Raunsø; Christian Torp-Pedersen; Gunnar Hilmar Gislason
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

9.  Seasonality, incidence and prognosis in atrial fibrillation and stroke in Denmark and New Zealand.

Authors:  Anette Luther Christensen; Lars Hvilsted Rasmussen; Michael G Baker; Gregory Y H Lip; Claus Dethlefsen; Torben Bjerregaard Larsen
Journal:  BMJ Open       Date:  2012-08-24       Impact factor: 2.692

10.  Pre-existing atrial fibrillation and risk of arterial thromboembolism and death in intensive care unit patients: a population-based cohort study.

Authors:  Jacob Gamst; Christian Fynbo Christiansen; Bodil Steen Rasmussen; Lars Hvilsted Rasmussen; Reimar Wernich Thomsen
Journal:  Crit Care       Date:  2015-08-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.